This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
News Medical on MSN
Metabolic reprogramming drives prostate cancer progression and treatment resistance
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Monte Rosa Therapeutics' stock dropped 17% after announcing MRT-2359's target shift to castration-resistant prostate cancer (CRPC) due to poor efficacy in lung and neuroendocrine cancers. The shift ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results